Combined radiation therapy and chemotherapy is the consensus standard therapy for NKTL patients, however, they are also often associated with high relapse rate and serious side effects.
The Cardiological Society of India (CSI) will soon launch a digital platform that will guide the people, patients and caregivers on various heart conditions.
Dr. Nageswara Rao Koneti's KONAR-MF Occluder receives US patent, offering a cost-effective solution for various heart defects. With global recognition, the device aims for FDA approval